Latent viral infections of the nervous system: Role of the host immune response

Revue Neurologique

Volumn 165, Issue 12, 2009, Pages 1039-1044

  Lafon, M ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

CD8; HSV 1; IFN ; Latency; Neuroimmunology; Neurons; Symbiosis; TLR; Virus

Indexed keywords

ADAPTIVE IMMUNITY; ARTICLE; BACTERIAL INFECTION; HERPES SIMPLEX VIRUS 1; IMMUNE RESPONSE; INNATE IMMUNITY; NEUROLOGIC DISEASE; SYMBIOSIS; VIRUS INFECTION;

ADAPTIVE IMMUNITY; BACTERIAL INFECTIONS; CD8-POSITIVE T-LYMPHOCYTES; CHEMOKINES; CYTOKINES; HERPES SIMPLEX; HUMANS; IMMUNITY, INNATE; INTERFERON-GAMMA; NERVOUS SYSTEM DISEASES; SIMPLEXVIRUS; SYMBIOSIS; TUMOR NECROSIS FACTOR-ALPHA; VIRUS DISEASES; VIRUS LATENCY;

EID: 71349087037     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurol.2009.09.010     Document Type: Article

References (71)

1. Agamanolis D.P., Leslie M.J., Caveny E.A., Guarner J., Shieh W.J., and Zaki S.R. Neuropathological findings in West Nile virus encephalitis: a case report. Ann Neurol. 54 (2003) 547-551
2. Andersson P.B., Perry V.H., and Gordon S. The acute inflammatory response to lipopolysaccharide in CNS parenchyma differs from that in other body tissues. Neuroscience. 48 (1992) 169-186
3. Anthony IC, Simmonds P, Bell JE. HIV infection of the central nervous system. In: Schokes C, editor. Neurotropic Viral Infections. 2008. p. 167-189.
4. Baloul L., Camelo S., and Lafon M. Up-regulation of Fas ligand (FasL) in the central nervous system: a mechanism of immune evasion by rabies virus. J Neurovirol. 10 (2004) 372-382
5. Bantug G.R., Cekinovic D., Bradford R., Koontz T., Jonjic S., and Britt W.J. CD8+ T lymphocytes control murine cytomegalovirus replication in the central nervous system of newborn animals. J Immunol. 181 (2008) 2111-2123
6. Barton E.S., White D.W., Cathelyn J.S., Brett-McClellan K.A., Engle M., Diamond M.S., et al. Herpesvirus latency confers symbiotic protection from bacterial infection. Nature. 447 (2007) 326-329
7. Bauer M., Brakebusch C., Coisne C., Sixt M., Wekerle H., Engelhardt B., et al. Beta1 integrins differentially control extravasation of inflammatory cell subsets into the CNS during autoimmunity. Proc Natl Acad Sci U S A. 106 (2009) 1920-1925
8. Berger J.R., and Koralnik I.J. Progressive multifocal leukoencephalopathy and natalizumab--unforeseen consequences. N Engl J Med. 353 (2005) 414-416
9. Brehin A.C., Mouries J., Frenkiel M.P., Dadaglio G., Despres P., Lafon M., et al. Dynamics of immune cell recruitment during West Nile encephalitis and identification of a new CD19+B220-BST-2+ leukocyte population. J Immunol. 180 (2008) 6760-6767
10. Brinkmann M.M., Spooner E., Hoebe K., Beutler B., Ploegh H.L., and Kim Y.M. The interaction between the ER membrane protein UNC93B and TLR3, 7, and 9 is crucial for TLR signaling. J Cell Biol. 177 (2007) 265-275
11. Byrnes A.P., MacLaren R.E., and Charlton H.M. Immunological instability of persistent adenovirus vectors in the brain: peripheral exposure to vector leads to renewed inflammation, reduced gene expression, and demyelination. J Neurosci. 16 (1996) 3045-3055
12. Byrnes A.P., Wood M.J., and Charlton H.M. Role of T cells in inflammation caused by adenovirus vectors in the brain. Gene Ther. 3 (1996) 644-651
13. Casrouge A., Zhang S.Y., Eidenschenk C., Jouanguy E., Puel A., Yang K., et al. Herpes simplex virus encephalitis in human UNC-93B deficiency. Science. 314 (2006) 308-312
14. Coisne C., Mao W., and Engelhardt B. Cutting edge: Natalizumab blocks adhesion but not initial contact of human T cells to the blood-brain barrier in vivo in an animal model of multiple sclerosis. J Immunol. 182 (2009) 5909-5913
15. Daffis S., Samuel M.A., Suthar M.S., Gale Jr. M., and Diamond M.S. Toll-like receptor 3 has a protective role against West Nile virus infection. J Virol. 82 (2008) 10349-10358
16. Delhaye S., Paul S., Blakqori G., Minet M., Weber F., Staeheli P., et al. Neurons produce type I IFN during viral encephalitis. Proc Natl Acad Sci U S A. 103 (2006) 7835-7840
17. Divito S., Cherpes T.L., and Hendricks R.L. A triple entente: virus, neurons, and CD8+ T cells maintain HSV-1 latency. Immunol Res. 36 (2006) 119-126
18. Dolei A., and Perron H. The multiple sclerosis-associated retrovirus and its HERV-W endogenous family: a biological interface between virology, genetics, and immunology in human physiology and disease. J Neurovirol. 15 (2009) 4-13
19. Engelhardt B. The blood-central nervous system barriers actively control immune cell entry into the central nervous system. Curr Pharm Des. 14 (2008) 1555-1565
20. Feldman L.T., Ellison A.R., Voytek C.C., Yang L., Krause P., and Margolis T.P. Spontaneous molecular reactivation of herpes simplex virus type 1 latency in mice. Proc Natl Acad Sci U S A. 99 (2002) 978-983
21. Furr S.R., Chauhan V.S., Sterka Jr. D., Grdzelishvili V., and Marriott I. Characterization of retinoic acid-inducible gene-I expression in primary murine glia following exposure to vesicular stomatitis virus. J Neurovirol (2008) 1-11
22. Galea I., Bechmann I., and Perry V.H. What is immune privilege (not)?. Trends Immunol. 28 (2007) 12-18
23. Galelli A., Baloul L., and Lafon M. Abortive rabies virus central nervous infection is controlled by T lymphocyte local recruitment and induction of apoptosis. J Neurovirol. 6 (2000) 359-372
24. Garcia-Sastre A., and Biron C.A. Type 1 IFNs and the virus-host relationship: a lesson in detente. Science. 312 (2006) 879-882
25. Gesser R.M., Valyi-Nagy T., and Fraser N.W. Restricted herpes simplex virus type 1 gene expression within sensory neurons in the absence of functional B and T lymphocytes. Virology. 200 (1994) 791-795
26. Griffin D.E. Immune responses to RNA-virus infections of the CNS. Nat Rev Immunol. 3 (2003) 493-502
27. Griffiths M., Neal J.W., and Gasque P. Innate immunity and protective neuroinflammation: new emphasis on the role of neuroimmune regulatory proteins. Int Rev Neurobiol. 82 (2007) 29-55
28. Halford W.P., and Schaffer P.A. ICP0 is required for efficient reactivation of herpes simplex virus type 1 from neuronal latency. J Virol. 75 (2001) 3240-3249
29. Hoek R.M., Ruuls S.R., Murphy C.A., Wright G.J., Goddard R., Zurawski S.M., et al. Down-regulation of the macrophage lineage through interaction with OX2 (CD200). Science. 290 (2000) 1768-1771
30. Ireland D.D., Stohlman S.A., Hinton D.R., Atkinson R., and Bergmann C.C. Type I IFNs are essential in controlling neurotropic coronavirus infection irrespective of functional CD8 T cells. J Virol. 82 (2008) 300-310
31. Jackson A.C., Rossiter J.P., and Lafon M. Expression of Toll-like receptor 3 in the human cerebellar cortex in rabies, herpes simplex encephalitis, and other neurological diseases. J Neurovirol. 12 (2006) 229-234
32. Jackson S.A., and DeLuca N.A. Relationship of herpes simplex virus genome configuration to productive and persistent infections. Proc Natl Acad Sci U S A. 100 (2003) 7871-7876
33. Kelley T.W., Prayson R.A., Ruiz A.I., Isada C.M., and Gordon S.M. The neuropathology of West Nile virus meningoencephalitis. A report of two cases and review of the literature. Am J Clin Pathol. 119 (2003) 749-753
34. Khanna K.M., Bonneau R.H., Kinchington P.R., and Hendricks R.L. Herpes simplex virus-specific memory CD8+ T cells are selectively activated and retained in latently infected sensory ganglia. Immunity. 18 (2003) 593-603
35. Knickelbein J.E., Khanna K.M., Yee M.B., Baty C.J., Kinchington P.R., and Hendricks R.L. Noncytotoxic lytic granule-mediated CD8+ T cell inhibition of HSV-1 reactivation from neuronal latency. Science. 322 (2008) 268-271
36. Krug A., Luker G.D., Barchet W., Leib D.A., Akira S., and Colonna M. Herpes simplex virus type 1 activates murine natural IFN-producing cells through toll-like receptor 9. Blood. 103 (2004) 1433-1437
37. Kurt-Jones E.A., Chan M., Zhou S., Wang J., Reed G., Bronson R., et al. Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis. Proc Natl Acad Sci U S A. 101 (2004) 1315-1320
38. Lafon M., Megret F., Lafage M., and Prehaud C. The innate immune facet of brain: human neurons express TLR-3 and sense viral dsRNA. J Mol Neurosci. 29 (2006) 185-194
39. Lafon M., Megret F., Meuth S.G., Simon O., Velandia Romero M.L., Lafage M., et al. Detrimental contribution of the immuno-inhibitor B7-H1 to rabies virus encephalitis. J Immunol. 180 (2008) 7506-7515
40. Liu Y., Teige I., Birnir B., and Issazadeh-Navikas S. Neuron-mediated generation of regulatory T cells from encephalitogenic T cells suppresses EAE. Nat Med. 12 (2006) 518-525
41. Lund J., Sato A., Akira S., Medzhitov R., and Iwasaki A. Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells. J Exp Med. 198 (2003) 513-520
42. Lunemann J.D., and Munz C. EBV in MS: guilty by association?. Trends Immunol. 30 (2009) 243-248
43. Margolis D.M., Rabson A.B., Straus S.E., and Ostrove J.M. Transactivation of the HIV-1 LTR by HSV-1 immediate-early genes. Virology. 186 (1992) 788-791
44. Medawar P.B. The Nobel Lectures in Immunology. The Nobel Prize for Physiology or Medicine, 1960. Immunological tolerance. Scand J Immunol. 33 (1991) 337-344
45. Menager P., Roux P., Megret F., Bourgeois J.P., Le Sourd A.M., Danckaert A., et al. Toll-like receptor 3 (TLR3) plays a major role in the formation of rabies virus Negri Bodies. PLoS Pathog. 5 (2009) e1000315
46. Meuth S.G., Simon O.J., Grimm A., Melzer N., Herrmann A.M., Spitzer P., et al. CNS inflammation and neuronal degeneration is aggravated by impaired CD200-CD200R-mediated macrophage silencing. J Neuroimmunol. 194 (2008) 62-69
47. Niederkorn J.Y. See no evil, hear no evil, do no evil: the lessons of immune privilege. Nat Immunol. 7 (2006) 354-359
48. Okumura A., Abe S., Kidokoro H., and Mizuguchi M. Acute necrotizing encephalopathy: a comparison between influenza and non-influenza cases. Microbiol Immunol. 53 (2009) 277-280
49. Olson J.K., and Miller S.D. Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs. J Immunol. 173 (2004) 3916-3924
50. Perron H., Bernard C., Bertrand J.B., Lang A.B., Popa I., Sanhadji K., et al. Endogenous retroviral genes. Herpesviruses and gender in Multiple Sclerosis. J Neurol Sci (2009)
51. Perron H., Jouvin-Marche E., Michel M., Ounanian-Paraz A., Camelo S., Dumon A., et al. Multiple sclerosis retrovirus particles and recombinant envelope trigger an abnormal immune response in vitro, by inducing polyclonal Vbeta16 T-lymphocyte activation. Virology. 287 (2001) 321-332
52. Prehaud C., Megret F., Lafage M., and Lafon M. Virus infection switches TLR-3-positive human neurons to become strong producers of beta IFN. J Virol. 79 (2005) 12893-12904
53. Randall R.E., and Goodbourn S. IFNs and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J Gen Virol. 89 (2008) 1-47
54. Rasmussen S.B., Sorensen L.N., Malmgaard L., Ank N., Baines J.D., Chen Z.J., et al. Type I IFN production during herpes simplex virus infection is controlled by cell-type-specific viral recognition through Toll-like receptor 9, the mitochondrial antiviral signaling protein pathway, and novel recognition systems. J Virol. 81 (2007) 13315-13324
55. Robertson B., Kong G., Peng Z., Bentivoglio M., and Kristensson K. IFN-gamma-responsive neuronal sites in the normal rat brain: receptor protein distribution and cell activation revealed by Fos induction. Brain Res Bull. 52 (2000) 61-74
56. Sawtell N.M. Quantitative analysis of herpes simplex virus reactivation in vivo demonstrates that reactivation in the nervous system is not inhibited at early times postinoculation. J Virol. 77 (2003) 4127-4138
57. Simmons A., and Tscharke D.C. Anti-CD8 impairs clearance of herpes simplex virus from the nervous system: implications for the fate of virally infected neurons. J Exp Med. 175 (1992) 1337-1344
58. Sorensen L.N., Reinert L.S., Malmgaard L., Bartholdy C., Thomsen A.R., and Paludan S.R. TLR2 and TLR9 synergistically control herpes simplex virus infection in the brain. J Immunol. 181 (2008) 8604-8612
59. Steed A.L., Barton E.S., Tibbetts S.A., Popkin D.L., Lutzke M.L., Rochford R., et al. Gamma IFN blocks gammaherpesvirus reactivation from latency. J Virol. 80 (2006) 192-200
60. Stevens J.G. Defining herpes simplex genes involved in neurovirulence and neuroinvasiveness. Curr Eye Res. 6 (1987) 63-67
61. Stevenson P.G., Hawke S., Sloan D.J., and Bangham C.R. The immunogenicity of intracerebral virus infection depends on anatomical site. J Virol. 71 (1997) 145-151
62. Stuve O. The effects of natalizumab on the innate and adaptive immune system in the central nervous system. J Neurol Sci. 274 (2008) 39-41
63. Tai A.K., Luka J., Ablashi D., and Huber B.T. HHV-6A infection induces expression of HERV-K18-encoded superantigen. J Clin Virol (2009)
64. Tang S.C., Arumugam T.V., Xu X., Cheng A., Mughal M.R., Jo D.G., et al. Pivotal role for neuronal Toll-like receptors in ischemic brain injury and functional deficits. Proc Natl Acad Sci U S A. 104 (2007) 13798-13803
65. Tang S.C., Lathia J.D., Selvaraj P.K., Jo D.G., Mughal M.R., Cheng A., et al. Toll-like receptor-4 mediates neuronal apoptosis induced by amyloid beta-peptide and the membrane lipid peroxidation product 4-hydroxynonenal. Exp Neurol. 213 (2008) 114-121
66. Vikman K., Robertson B., Grant G., Liljeborg A., and Kristensson K. IFN-gamma receptors are expressed at synapses in the rat superficial dorsal horn and lateral spinal nucleus. J Neurocytol. 27 (1998) 749-759
67. Weller R.O., Djuanda E., Yow H.Y., and Carare R.O. Lymphatic drainage of the brain and the pathophysiology of neurological disease. Acta Neuropathol. 117 (2009) 1-14
68. Wright G.J., Puklavec M.J., Willis A.C., Hoek R.M., Sedgwick J.D., Brown M.H., et al. Lymphoid/neuronal cell surface OX2 glycoprotein recognizes a novel receptor on macrophages implicated in the control of their function. Immunity. 13 (2000) 233-242
69. Yang L., Voytek C.C., and Margolis T.P. Immunohistochemical analysis of primary sensory neurons latently infected with herpes simplex virus type 1. J Virol. 74 (2000) 209-217
70. Zhang S.Y., Jouanguy E., Sancho-Shimizu V., von Bernuth H., Yang K., Abel L., et al. Human Toll-like receptor-dependent induction of IFNs in protective immunity to viruses. Immunol Rev. 220 (2007) 225-236
71. Zhou L.X., Wang Y.J., Wang Y., Zhou S., Hu L., Ye, et al. Activation of toll-like receptor-3 induces IFN-lambda expression in human neuronal cells. Neuroscience. 159 (2009) 629-637